Aesthetic Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aesthetic Implants Pipeline Market Report Overview

Aesthetic implants are intended to enhance the physical appearance and improve the image. Implantation is usually performed for cosmetic purposes as well as to rectify the deformed shape of the organ.

The aesthetic implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Implants

·       Breast Implants

·       Shaped Gel Implants

·       Breast Meshes

·       Other Facial Implants

Key Territories ·       The United States

·       Europe

·       Israel

·       United Kingdom

·       China

Key Regulatory Paths ·       PMA

·       CE

·       510(k)

·       TGA

·       NMPA

Leading Companies ·       3D Bio Corp

·       Aeon Astron Corporation

·       Allergan Aesthetics

·       Apex Medical Device Design LLC

·       Arula Technologies

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

 Buy the Full Report for More Insights into the Aesthetic Implants Pipeline Market

Download a Free Report Sample

Aesthetic Implants Pipeline Market Segments

A few of the key segments in the aesthetic implants pipeline market are implants, breast implants, shaped gel implants, breast meshes, and other facial implants. Implants had the highest number of pipeline products in the aesthetic implants pipeline market as of October 2024.

Aesthetic Implants Pipeline Market Analysis by Segments, 2024 (%)

Aesthetic Implants Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Aesthetic Implants Pipeline Market

Download a Free Report Sample

Aesthetic Implants Pipeline Market Segmentation by Territories

The United States, Europe, Israel, the United Kingdom, and China among others are a few of the key territories of the aesthetic implants pipeline market. As of October 2024, the US accounte for the highest number of pipeline products.

Aesthetic Implants Pipeline Market Analysis by Territories, 2024 (%)

Aesthetic Implants Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Aesthetic Implants Pipeline Market

Download a Free Report Sample

Aesthetic Implants Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the aesthetic implants pipeline products market are PMA, CE, 510(k), TGA, and NMPA. As of October 2024, PMA was the most followed pathway for pipeline products in the aesthetic implants market.

Aesthetic Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Aesthetic Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Aesthetic Implants Pipeline Market

Download a Free Report Sample

Aesthetic Implants Pipeline Market – Competitive Landscape

A few of the key companies associated with the Aesthetic Implants pipeline market are 3D Bio Corp, Aeon Astron Corporation, Allergan Aesthetics, Apex Medical Device Design LLC, and Arula Technologies among others.

3D Bio Corp: 3D Bio Corp (3D Bio) is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company’s pipeline products include AuriNovo, AnnuNovo, DiscNovo, and NasaNovo. The company provides a bio-printing platform that focuses on whole-tissue living implants for near-term indications. It has lab and factory facilities in Ithaca, New York, and an engineering workshop in Brooklyn, New York.

Allergan Aesthetics: Allergan Aesthetics, a subsidiary of AbbVie Inc. is a pharmaceutical company that develops, manufactures, and has a market portfolio of leading aesthetics brands and products. It is headquartered in Irvine, California the US.

Aesthetic Implants Pipeline Market Analysis by Companies, 2024
Aesthetic Implants Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Aesthetic Implants Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Aesthetic Implants Pipeline Market Segments Outlook (2024)

  • Implants
  • Breast Implants
  • Shaped Gel Implants
  • Breast Meshes
  • Other Facial Implants

Aesthetic Implants Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Israel
  • United Kingdom
  • China

Aesthetic Implants Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • 510(k)
  • TGA
  • NMPA

Scope

This report provides:

  • Extensive coverage of the aesthetic implants under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • The major players involved in the development of aesthetic implants and lists all their pipeline projects.
  • The coverage of pipeline products is based on various stages of development ranging from early development to the approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of aesthetic implants under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Bio Corp
Aeon Astron Corporation
Allergan Aesthetics
Apex Medical Device Design LLC
Arula Technolgies
BellaSeno GmbH
BioPlus Co Ltd
Biostruxs LLC
Collplant Biotechnologies Ltd
Emory University
Establishment Labs SA
FixNip Ltd
GC Aesthetics Plc
Hansjorg Wyss Institute for Biologically Inspired Engineering
Healshape SAS
ImpLite Ltd.
Innovia LLC
Lattice Medical
LifeCell Corp
Melodi Health Inc
Mentor Worldwide LLC
MTF Biologics
Nanjing Premier Medical Technology Co Ltd
Neosthetic, LLC
Osteopore International Pte Ltd
Oxtex Ltd (Inactive)
Plcoskin Co Ltd
PolyNovo Biomaterials Pty Ltd
Prayasta 3D Inventions Pvt Ltd
PrintBio Inc
Surgalign Spine Technologies Inc
Symatese Aesthetics
Tensive SRL
TeVido BioDevices LLC
Uronext LLC
VisageX Medical Ltd

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Aesthetic Implants Overview

3 Products under Development

3.1 Aesthetic Implants – Pipeline Products by Stage of Development

3.2 Aesthetic Implants – Pipeline Products by Segment

3.3 Aesthetic Implants – Pipeline Products by Territory

3.4 Aesthetic Implants – Pipeline Products by Regulatory Path

3.5 Aesthetic Implants – Pipeline Products by Estimated Approval Date

3.6 Aesthetic Implants – Ongoing Clinical Trials

4 Aesthetic Implants – Pipeline Products under Development by Companies

4.1 Aesthetic Implants Companies – Pipeline Products by Stage of Development

4.2 Aesthetic Implants – Pipeline Products by Stage of Development

5 Aesthetic Implants Companies and Product Overview

5.1 3D Bio Corp Company Overview

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aeon Astron Corporation Company Overview

5.2.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.3 Allergan Aesthetics Company Overview

5.3.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview

5.4 Apex Medical Device Design LLC Company Overview

5.4.1 Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview

5.5 Arula Technolgies Company Overview

5.5.1 Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview

5.6 BellaSeno GmbH Company Overview

5.6.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.7 BioPlus Co Ltd Company Overview

5.7.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.8 Biostruxs LLC Company Overview

5.8.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview

5.9 Collplant Biotechnologies Ltd Company Overview

5.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.10 Emory University Company Overview

5.10.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview

5.11 Establishment Labs SA Company Overview

5.11.1 Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview

5.12 FixNip Ltd Company Overview

5.12.1 FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.13 GC Aesthetics Plc Company Overview

5.13.1 GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview

5.14.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview

5.15 Healshape SAS Company Overview

5.15.1 Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview

5.16 ImpLite Ltd. Company Overview

5.16.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.17 Innovia LLC Company Overview

5.17.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 Lattice Medical Company Overview

5.18.1 Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview

5.19 LifeCell Corp Company Overview

5.19.1 LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview

5.20 Melodi Health Inc Company Overview

5.20.1 Melodi Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.21 Mentor Worldwide LLC Company Overview

5.21.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview

5.22 MTF Biologics Company Overview

5.22.1 MTF Biologics Pipeline Products & Ongoing Clinical Trials Overview

5.23 Nanjing Premier Medical Technology Co Ltd Company Overview

5.23.1 Nanjing Premier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.24 Neosthetic, LLC Company Overview

5.24.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.25 Osteopore International Pte Ltd Company Overview

5.25.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.26 Oxtex Ltd (Inactive) Company Overview

5.26.1 Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.27 Plcoskin Co Ltd Company Overview

5.27.1 Plcoskin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.28 PolyNovo Biomaterials Pty Ltd Company Overview

5.28.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.29 Prayasta 3D Inventions Pvt Ltd Company Overview

5.29.1 Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.30 PrintBio Inc Company Overview

5.30.1 PrintBio Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Surgalign Spine Technologies Inc Company Overview

5.31.1 Surgalign Spine Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.32 Symatese Aesthetics Company Overview

5.32.1 Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview

5.33 Tensive SRL Company Overview

5.33.1 Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview

5.34 TeVido BioDevices LLC Company Overview

5.34.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview

5.35 Uronext LLC Company Overview

5.35.1 Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview

5.36 VisageX Medical Ltd Company Overview

5.36.1 VisageX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Aesthetic Implants- Recent Developments

6.1 Oct 02, 2024: First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

6.2 Sep 26, 2024: Establishment Labs Receives U.S. FDA Approval for Motiva Implants

6.3 Sep 17, 2024: GC Aesthetics Launches YOUTHLY : A New Era for Breast Implants in China

6.4 Sep 13, 2024: Mentor Worldwide Receives 510(K) Clearance For MENTOR MemoryGel Enhance Single Use Gel Sizer

6.5 Sep 12, 2024: POLYTECH Expands Portfolio with New Opticon Plus Breast Implant

6.6 Aug 19, 2024: CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

6.7 Aug 12, 2024: Mentor Worldwide Receives 510(K) Clearance for MENTOR CPX4 PLUS Enhance Breast Tissue Expander

6.8 Aug 05, 2024: Keosan Trading Receives FDA 510(k) Clearance for MISTI Silicone Implant

6.9 Aug 05, 2024: Create New Materials Using Precision Multi-ion Implantation

6.10 Jun 12, 2024: BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients

6.11 Jun 06, 2024: Collplant Successfully Bio-prints 200cc Commercial-size Regenerative Breast Implants And Reports Additional Positive Pre-clinical Data

6.12 May 03, 2024: Announcing the Launch of Serene Structured Saline Breast Implants

6.13 May 02, 2024: Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at the Aesthetic Meeting 2024

6.14 Apr 17, 2024: Establishment Labs Announces Participation in The Aesthetic Meeting 2024

6.15 Mar 19, 2024: The Aesthetic Society and The Aesthetic Foundation Launch ARISE– American Registry for Breast Implant Surveillance

6.16 Jan 31, 2024: New Investigator-Initiated Clinical Trials of BellaSeno´s Resorbable Tissue Regeneration scaffolds to be Conducted in Europe

6.17 Jan 26, 2024: New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics’ PERLE Breast Implant

6.18 Jan 08, 2024: Collplant’s CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

6.19 Jan 02, 2024: Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

6.20 Jan 02, 2024: Collplant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

6.21 Dec 06, 2023: Keosan Trading Receives 510(K) Clearance For FITme Customized Silicone Implant

6.22 Nov 10, 2023: PIP Breast Implants: Last Claim for Damages against TUV Rheinland in Germany Definitively Dismiss

6.23 Nov 09, 2023: Comprehensive Study Highlights Rigi10 Malleable Penile Prosthesis Safety Outcomes Implanted Worldwide

6.24 Nov 09, 2023: Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China

6.25 Oct 30, 2023: Motiva Receives 510(K) Clearance For Motiva Flora SmoothSilk Tissue Expander

6.26 Oct 30, 2023: BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds

6.27 Oct 26, 2023: GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally

6.28 Oct 24, 2023: MTF Biologics Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction

6.29 Oct 16, 2023: FDA clears Establishment Labs’ magnetic-free breast tissue expander

6.30 Oct 13, 2023: Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Aesthetic Implants – Pipeline Products by Stage of Development

Aesthetic Implants – Pipeline Products by Segment

Aesthetic Implants – Pipeline Products by Territory

Aesthetic Implants – Pipeline Products by Regulatory Path

Aesthetic Implants – Pipeline Products by Estimated Approval Date

Aesthetic Implants – Ongoing Clinical Trials

Aesthetic Implants Companies – Pipeline Products by Stage of Development

Aesthetic Implants – Pipeline Products by Stage of Development

3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Breast Implant – Lupectomy Reconstruction – Product Status

3D Printed Breast Implant – Lupectomy Reconstruction – Product Description

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

Prosthetic Chin – Product Status

Prosthetic Chin – Product Description

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview

Inspira TF2 – Breast Augmentation – Product Status

Inspira TF2 – Breast Augmentation – Product Description

Larger Inspira TE – Product Status

Larger Inspira TE – Product Description

Phoenix – Breast Augmentation – Product Status

Phoenix – Breast Augmentation – Product Description

Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview

DefyGravity – Product Status

DefyGravity – Product Description

Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview

Breast Prosthesis – Product Status

Breast Prosthesis – Product Description

BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Status

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Description

Senella Scaffold – Product Status

Senella Scaffold – Product Description

BellaSeno GmbH – Ongoing Clinical Trials Overview

Senella Scaffold – A Pivotal Clinical Study to Evaluate the Efficacy Breast Scaffolds in the Treatment of Breast Diseases

Senella Scaffold – Clinical Trial Evaluating Feasibility and Safety of Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation with Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery

3D Printed Pectus Scaffold Implant – Pectus Excavatum – A Clinical Trial Evaluating Medical-Grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage

3D Printed Pectus Scaffold Implant – Pectus Excavatum – An Investigator-Initiated Clinical Trial to Evaluate the Effect of Novel Regenerative Scaffolds for Bone Reconstruction and Chest-Wall Defects (Pectus Excavatum)

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage (IT)

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Biological Breast – Product Status

Biological Breast – Product Description

Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview

BioBreast Scaffold – Product Status

BioBreast Scaffold – Product Description

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

3D Bioprinted Regenerative Breast Implant – Product Status

3D Bioprinted Regenerative Breast Implant – Product Description

Injectable Breast Implant – Product Status

Injectable Breast Implant – Product Description

Emory University Pipeline Products & Ongoing Clinical Trials Overview

Nasolabial Fold Implant – Product Status

Nasolabial Fold Implant – Product Description

Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview

Mia Femtech – Product Status

Mia Femtech – Product Description

Motiva Ergonomix2 – Product Status

Motiva Ergonomix2 – Product Description

Motiva Ergonomix2 Diamond Breast Implant – Product Status

Motiva Ergonomix2 Diamond Breast Implant – Product Description

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Status

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Description

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Status

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Description

Motiva MIA – Product Status

Motiva MIA – Product Description

Establishment Labs SA – Ongoing Clinical Trials Overview

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery

Motiva Ergonomix2 – Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study

Motiva MIA – A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants

FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview

FixNip NRI – Product Status

FixNip NRI – Product Description

GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview

PERLE – Product Status

PERLE – Product Description

GC Aesthetics Plc – Ongoing Clinical Trials Overview

PERLE – A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation

Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview

Breast Reconstruction Implant – Product Status

Breast Reconstruction Implant – Product Description

Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Breast Implant – Product Status

3D Printed Breast Implant – Product Description

ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Freedom Implant – Product Status

Freedom Implant – Product Description

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview

Breast Implant Shell – Product Status

Breast Implant Shell – Product Description

Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview

MATTISSE – Product Status

MATTISSE – Product Description

Lattice Medical – Ongoing Clinical Trials Overview

MATTISSE – First-in-human Study of MATTISSE® Tissue Engineering Chamber in Adult Female After Total Mastectomy for Breast Cancer in Immediate or Delayed 2-stage Tissue Expander Reconstruction or Conversion From Implant-based to Autologous Reconstruction

LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview

Artia – Breast Reconstruction – Product Status

Artia – Breast Reconstruction – Product Description

Melodi Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Melodi Matrix – Product Status

Melodi Matrix – Product Description

Melodi Health Inc – Ongoing Clinical Trials Overview

Melodi Matrix – Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction with Infection Outcomes Assessment (ARIA)

Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview

Mentor – Becker Round Adjustable Gel Implant – Product Status

Mentor – Becker Round Adjustable Gel Implant – Product Description

MTF Biologics Pipeline Products & Ongoing Clinical Trials Overview

FlexHD Pliable – Implant-Based Breast Reconstruction – Product Status

FlexHD Pliable – Implant-Based Breast Reconstruction – Product Description

Nanjing Premier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

PPDO Facial Implant – Product Status

PPDO Facial Implant – Product Description

Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview

Neosthetic Breast Implant – Product Status

Neosthetic Breast Implant – Product Description

Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

Aesthetic Genioplasty (Chin) Device – Product Status

Aesthetic Genioplasty (Chin) Device – Product Description

Breast Reconstruction Device – Product Status

Breast Reconstruction Device – Product Description

Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Oxtex Tissue Expander – Reconstructive Surgery – Product Status

Oxtex Tissue Expander – Reconstructive Surgery – Product Description

Plcoskin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Breast Implant – Product Status

3D Printed Breast Implant – Product Description

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

NovoSorb – Breast Reconstruction – Product Status

NovoSorb – Breast Reconstruction – Product Description

Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Silicone-Based Breast Prosthesis – Product Status

Silicone-Based Breast Prosthesis – Product Description

PrintBio Inc Pipeline Products & Ongoing Clinical Trials Overview

3D Matrix Gen 2 – Product Status

3D Matrix Gen 2 – Product Description

Surgalign Spine Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Cortiva Allograft Dermis Implant – Breast Reconstruction – Product Status

Cortiva Allograft Dermis Implant – Breast Reconstruction – Product Description

Surgalign Spine Technologies Inc – Ongoing Clinical Trials Overview

Cortiva Allograft Dermis Implant – Breast Reconstruction – Acellular Dermal Matrix Investigation in Breast Reconstruction

Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Status

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Description

Symatese Aesthetics – Ongoing Clinical Trials Overview

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Evaluation of the Safety and Performance of Symatese Aesthetics Estyme Matrix Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study)

Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview

REGENERA Breast Implant – Product Status

REGENERA Breast Implant – Product Description

Tensive SRL – Ongoing Clinical Trials Overview

REGENERA Breast Implant – A Pilot Study of REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy – Long-term Follow-up

TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Breast Implant – Product Status

3D Printed Breast Implant – Product Description

Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview

Alloy Penile Prosthesis – Product Status

Alloy Penile Prosthesis – Product Description

VisageX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

Facial Implant – Product Status

Facial Implant – Product Description

Glossary

Figures

Aesthetic Implants – Pipeline Products by Stage of Development

Aesthetic Implants – Pipeline Products by Segment

Aesthetic Implants – Pipeline Products by Territory

Aesthetic Implants – Pipeline Products by Regulatory Path

Aesthetic Implants – Pipeline Products by Estimated Approval Date

Aesthetic Implants – Ongoing Clinical Trials

Frequently asked questions

Aesthetic Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Aesthetic Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aesthetic Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Aesthetic Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.